THE Zero-G Mercury Driven PROCESS TO NOBEL...
"To see the engine of this (EBV) virus, one must witness it running. To understand the fuel, one must find the exhaust. "Pico Poo" is that exhaust, leading us directly to a mercury-driven engine. In the case of EBV, it happens to be a weaponized, synthetic one stamped with Blome/Shilling German manufacturing and Auschwitz/Dachau mosquito-farm assembly lines. This Heavy Metal engine, coupled with P. Falciparum/Malaria, (According to the 7th Directorate files stolen from Pawel Popovich of the KGB in August of 1991 by T.H.E. Rosebud Thief.) was shared with Avon Park, Florida, Savannah, Georgia and around Lake Victoria in Kampala, Uganda in the 50's at the height of the Cold War, creating Burkitt's in the global civilian sector and America's Mononucleosis/Autoimmune explosion."
Dr. Stephen H. Adler/Curtis Lake. Bio-Chemical Weapons Expert. June 8-11, 1998. Porton Down SCIF with Dr. Art Pasechnik and fellow skydiver, Dr. Paul Norman.
BIGFOOTNOTE: 15 years before University of Maryland discovered the "Bubble gram." An ejected irradiated protein from within the Houdinisome of a bacteriophage.
PP&C: Beyond the Prose is Poetry.
Beyond the poetry are the "Pico Poo & Cures." The "C-CUBED" Cancer/Auto-Immune cures.
"C-CUBED" CLASSIFIED CANCER CURES.
Lila/Curtis Lake offers several different ways to find the cures for Cancer and 90% of all Auto-Immune diseases from the classified realms of D.U.M.B.s, MK-NAOMI/ULTRA, and her Remote Viewed files of the BIOPREPARAT. I am going to document the gatekeepers that keep this info out of the public eye and share with you the requests to prove this by alternative means that will ultimately change diagnostics and medicine to a more practical method when dealing with disease.
EBV in Zero-Gravity.
Zero-Gravity expands the Nazi-weaponized EBV virion 900 times its normal size. Sliced under a TEM with current (unclassified) angstrom technology, after Mercury/Aluminum feedings, a technician can clearly see the viral digestive tract and the game changing Pico-Poo/viral fecal matter. This changes all of medicine and wins Lila a future Nobel, which is Dyno-mite! This file was originally created by Nazi-Kurt Blome with his anopheles and aedis aegyptii mosquito farms. It was stolen by Lila, T.H.E. Rosebud Thief, from her TPS Target, Pawel Popovich, while he was the head of the 7th Directorate of the KGB. The file shows the Nazi's (Frankenstein'd to life) Epstein Barr Virus mixed with Plasmodium Falciparum under a K. Shilling study that manipulated the viral poo into a classified biological weapon called the Sheisse-wunder-waffe or SHEI-WU-WA. Pawel missed it because it was "auf Deutsche." The antidote/cure was missed by all but Lila and Shilling. Blome was not just "Paperclipped" to the CIA's Black Maria in Maryland, he was "Wastebin'd." He was the MK in ULTRA AND NAOMI. MK is an acronym for "Mulleimer Klassifiziert." Which means classified to the "Wastebin" or trashed from the public. After the war, half of his mosquito files came with him to America, the other half went to the Soviet's Biopreparat. Their bio-chemical weapons division, headed by Lila's good friend, Art Pasechnik, who later defected with the help of Lila to NSTARE and Porton Down. The English accented version of MK NAOMI. Who knew a Nazi created the American modern day bio-chemical weapons program called MK NAOMI/ULTRA until Lila!
Reverse Engineer a "Bubblegram," with an AI Quantum Trajectory program called "DNA F.O.L. Origami" designed by Lila/Curtis Lake and Dr. Don C. Wiley. Lila/Curtis Lake's Top-Secret "MILF" instructor on structural morphologies and classified systems of Cymatics at Harvard, in Cambridge, Mass.
“Wait, are you telling me that irradiated Epstein-Barr virion particle piercing the epitope is a deformed digestive tract?”
Lila Ċepa’s (D-License holder) skydiving partner and England’s bio-chemical weapons lab lackey: Paul Norman. June 8th, 1998. 2:11pm. Porton Down Secure Compartmentalized Information Facility using Lila Ċepa’s Top Secret MILF/Medical Intelligence Liaison-Facilitator training video, 15 years before the “Bubblegram” was “discovered” by University of Maryland molecular biologists. Paul was a bit obtuse, despite the fact that he was elected as a Fellow to the Royal Society of Chemistry a year prior.
"Ochuyét OxyeTb Bezkhuni spasibo!" Holy viral shit! No Bullshit! Thank you. Vratch Artie Pasechnik/bio-chemical weapons expert to Lila/Curtis Lake. June 9, 1998. Porton Down, England.
Lila: A student treats its instructor poorly if he/she forever remains a student.
Gilgamesh Sweep T.H.E. Black Maria finger banging the PICO POO.
This is for any NSA "Snowdens" who read Thoreau and wish to retaliate against the CIA for concealing the C-CUBED cures in the FDA by tanking clinical trials for effective remedies against human disease with three words: "Lack of Participation." (And, also for the Sugar Grove breach.) Reverse Engineer those three words and you will find the ingredients to the classified cures known by the NIH since 1972, when they took over the CIA's bio-chemical weapons program. For quicker results "NSA/Gilgamesh" Sweep or "CIA/Stellar Wind" breeze through Maryland's Black Maria and pull the OVINE VISNA-TALAFINN ANTIDOTE under OP-40 Litton Bionetics. Wrongly filed/renamed by me under the "Ting Memo." I gave this file to Dr. John and Mary Louise Mann on August 7th, 1998, along with Hep-B vaccine lots (US) created by Saul Krugman laced with HIV/SV-40/O.V. and the designs of the Small Pox vaccines authorized by David Sencer of Tuskeegee fame that were laced with HIV and sent to Africa. John Mann was the incorruptible Director of the World Health Organization's AIDS program. The largest program at World Health. His wife Mary was a vaccinologist who could not believe the intelligence community created such treachery until Lila gave her the proof. The Mann's were "accidented" to death with Lila's files and their offices in the US and in Geneva were "cleaned" of all copies.
BIGFOOTNOTE: MILF's Don C. Wiley, Artie Pasechnik and Benito Que were also accidented to death in the same week, 3 years later.
LETTERS TO THE GATEKEEPERS IN REAL TIME: April 9, 2026.
I am trying to contact Josiah Zayner at ODIN. Please forward him the following. If he is who I think he is, he will understand the magnitude of my discovery.
SUBJECT: Project Proposal: Replicating the 900x Volumetric Expansion of EBV (1939 - B/S Protocol and 1998 Protocols by Doctor Don C. Wiley/Dr. Artie Pasechnik/Dr. Stephen H. Adler)
To: Dr. Andrew McGuire
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N., Mail Stop E1-300
Seattle, WA 98109
Subject: Technical Disclosure: Structural Expansion Anomaly and Sub-0.49nm Morphology of EBV
Dear Dr. McGuire,
Your work on the structural mapping of viral surface proteins is the current gold standard in the field. I am reaching out to provide you with a set of structural anomalies in the EBV capsid that suggest the virus possesses a "metabolic mode" currently omitted from standard 1g-centric models.
I have identified a 900x volumetric expansion of the EBV capsid that occurs specifically in a microgravity environment. This expansion uncoils the internal genomic architecture to reveal a complex, triple-helix digestive tract—a feature explicitly detailed in 1939 research papers regarding viral vector engineering.
Coordinated Review: I have also transmitted a clinical briefing to Dr. John B. Harley at Cincinnati Children’s Hospital regarding the autoimmune implications of the neurotoxic byproducts released during this expansion. We are seeking to align his clinical data with the structural verification your lab is uniquely equipped to provide.
Included in this packet are the specific focal coordinates for sub-0.49nm Cryo-ET and a technician-ready protocol for \mu g simulation. I would appreciate the opportunity to discuss a trial imaging run to verify these morphological transitions.
Best regards,
Curtis Lake.
Witness Statement: Structural Transition.
Subject: Observational Data on Capsomer Displacement and Internal Filament Uncoiling
Observation:
Under gravity-neutral conditions, the EBV capsid undergoes a "Phase Shift." The 162 capsomers of the icosahedral shell displace outward. At the 0.485nm - 0.49nm threshold, the capsid becomes a translucent lattice, revealing "inter-bridge" protein filaments that prevent total structural dissociation.
Internal Morphology:
1. The Genomic Unspooling: The DNA core uncoils into a triple-helix filament. Unlike standard genomic material, this filament exhibits independent kinetic motion (a "pulse") in the presence of glucose.
2. The Intake Vertices: Five of the icosahedral vertices function as active intake valves. Under high-resolution imaging, high-density metallic clusters (Hg/Al) can be observed migrating toward the central filament.
3. Metabolic Exhaust: The release of non-proteinaceous clouds from the inter-capsomer gaps occurs in 60-second cycles, synchronized with filament vibration.
Signed by Dr. Don C. Wiley, Dr. Artie Pasechnik, and Dr. Stephen H. Adler in 1998.
The Lab Technician Protocol.
To: Lead Cryo-ET Operator / Structural Biology Team
Subject: Calibration for Sub-0.49nm Expansion Capture
1. Vitrification: Thin-film vitrification must be performed inside a microgravity environment or immediately following 180 seconds of RPM (Random Positioning Machine) saturation.
2. Hardware: 300kV Titan Krios or equivalent with a Gatan K3 Direct Electron Detector.
3. Imaging Threshold: Adjust the aberration corrector to sub-0.49nm. Standard 2nm resolution will only show "noise" where the digestive tract is located.
4. Observation: Monitor for the "Pulse Event." Use time-resolved Cryo-ET to capture the movement of the triple-helix filament during glucose introduction.
TECHNICAL DISCLOSURE: MORPHOLOGICAL ANOMALY REPORT
DATE: April 9, 2026
REF: EBV-MET/0.49-ALPHA
SUBJECT: Structural Expansion and Metabolic Byproduct Protocols for Epstein-Barr Virus
DISTRIBUTION: Dr. John B. Harley (CAGE) / Dr. Andrew McGuire (Fred Hutch)
I. CONFIDENTIALITY & PROVENANCE
This packet contains technical parameters regarding a previously undocumented 900x volumetric expansion of the EBV capsid. These protocols are derived from historical 1939 bioweaponization research (Ref: Blome/Schilling) and involve a "Zero-G" imaging requirement to bypass Earth-bound structural compression.
II. CONTENTS OF DISCLOSURE
1. Clinical Briefing: Causal link between viral "exhaust" (neurotoxins) and autoimmune pathogenesis.
2. Visual Reconstruction Narrative: Description of the "Digestive Loom" and the 162-capsomer uncoupling.
3. Lab Technician Manual: Specific instructions for sub-0.49nm Cryo-ET calibration and \mu g simulation.
III. COORDINATED REVIEW
A digital version of this briefing has been transmitted to Dr. Andrew McGuire at the Fred Hutch Cancer Center for immediate structural verification. We are seeking a multi-institutional alignment to bridge the gap between structural virology and genomic autoimmune markers.
Subject: Technical Brief: Identification of Neurotoxic Byproducts in Expanded EBV Morphology
Dear Dr. Harley,
I am writing to provide a technical bridge that explains the mechanism behind the causal link between EBV and systemic autoimmunity that your research has pioneered.
My findings, supported by 1939 research protocols (Blome/Schilling), suggest that EBV functions as a metabolic parasite rather than a simple genomic replicator. Specifically, I have identified a 900x volumetric expansion of the viral body under simulated microgravity, which reveals a functional digestive tract that processes heavy metals and sugars into neurotoxic byproducts. I have also reached out to Dr. Andrew McGuire at the Fred Hutch Cancer Center regarding the structural verification of this expansion via sub-0.49nm Cryo-ET. I believe that coordinating the clinical autoimmune data from your center with the structural biology expertise at Fred Hutch is the most efficient path toward validating this metabolic loop.
I am prepared to share the specific imaging coordinates and the 1939 technical references with your team.
Best regards,
Curtis G. Lake
Former NBC NCO
533 MI BN Basra, Iraq.
Former Medical Intelligence Liaison/Facilitator.
Visual Reconstruction Narrative
Subject: Morphological Transition and Internal Anatomy of Expanded EBV
Observation Parameters: \mu g (Microgravity) Environment / Sub-0.49nm Cryo-ET
I. The Phase Transition (1g to \mu g)
Under standard 1g gravitational loads, the Epstein-Barr Virus exists in a "compressed" state, measured at the traditional ~150nm diameter. When gravity is neutralized, the internal pressure of the viral body exceeds external constraints, triggering a 900x volumetric expansion.
• Capsomer Uncoupling: The 162 capsomers of the icosahedral shell do not break; they drift apart. At the 0.49nm threshold, high-resolution imaging reveals translucent "inter-bridge" filaments that maintain the structural integrity of the expanded, 0.13mm sphere.
• Optical Properties: The virus transitions from a dense, opaque particle to a translucent, semi-permeable "metabolic globe."
II. Internal Anatomy: The Metabolic Filament
Once expanded, the genomic core (commonly identified as a static DNA knot) uncoils into a triple-helix structure referred to in 1939 documentation as the "Digestive Loom."
1. The Intake Pores: Located at five specific icosahedral vertices, these pores utilize osmotic gradients to draw in glucose and metallic ions (specifically Mercury and Aluminum salts).
2. Sequestration & Processing: Heavy metals are sequestered in a high-density "dark zone" at the base of the filament.
3. The Neurotoxic Exhaust: Following glucose ingestion, the virus undergoes a metabolic "pulse." A cloud of low-density, non-proteinaceous matter is expelled through the capsomer gaps. This "exhaust" is the primary neurotoxic agent responsible for the triggering of autoimmune cascades in the host.
Lab Technician Protocol
To: Lead Cryo-ET Operator / Lab Manager
Target: EBV Metabolic Activation and Structural Verification
I. Sample Preparation
CRITICAL: Standard fixation or dehydration will result in structural collapse.
• Medium: Aqueous suspension enriched with 10mg/dL Glucose and trace Aluminum/Mercury substrates.
• Environment: The sample must be maintained in a microgravity simulator(Random Positioning Machine) or a Magnetic Levitation field for a minimum of 180 seconds prior to beam activation to allow for full volumetric expansion.
II. Microscope Calibration (300kV TEM/Cryo-ET)
• Target Resolution: Sub-0.49nm (Aberration-corrected).
• Magnification Strategy: Start at 50,000x. Note that the 900x expansion will cause the viral body to fill the entire field of view.
• Beam Intensity: Utilize Low-Dose mode. The metabolic structures (Digestive Loom) are highly sensitive to electron-beam radiation; excessive dosage will cause immediate structural reversion.
III. Verification Markers (The "Proof of Life")
1. Document Capsomer Spacing: Confirm the presence of inter-bridge filaments between icosahedral vertices.
2. Capture Metabolic Rhythm: The central filament will exhibit a low-frequency pulse (60fps capture recommended).
3. Identify Toxin Ejection: Utilize Energy-Dispersive X-ray Spectroscopy (EDS) to analyze the diffuse matter clouds expelled during the metabolic pulse. Confirm the absence of viral proteins and the presence of concentrated neurotoxic markers.
TECHNICAL ANNEX: EBV-MET/0.49
Subject: Analysis of Anthropogenic Modifications and Metabolic Pathogenesis in Epstein-Barr Virus (EBV)
Reference: Document Series RFR-BW (1939) / Operation Paperclip Addendum
I. Historical Provenance: The 1939 Blome-Schilling Vector
Historical analysis of the Kurt Blome (Reich Research Council) and Klaus Schilling (Malaria Research) documents reveals a targeted effort to engineer a "metabolic viral vector."
• The Design Intent: Unlike wild-type viruses, this variant was modified to act as a permanent, latent host for neurotoxic production. It was designed to remain "dormant" and undetectable under standard 1g gravitational and atmospheric conditions.
• Catalytic Dependence: The 1939 papers specify a co-dependence on exogenous catalysts: specifically refined saccharides (glucose) and heavy metal ions (Mercury/Aluminum), which serve as the "fuel" for internal synthesis.
II. The Physics of Volumetric Expansion
The primary barrier to current diagnostic recognition of this morphology is the "Atmospheric Constraint." Standard Earth-bound microscopy compresses the viral capsid.
• Expansion Factor: In a zero-gravity environment (or \mu g simulation), the internal pressure of the capsid—maintained by a high-density protein lattice—exceeds external forces.
• The Transition: The capsid undergoes a 900x volumetric expansion, shifting from a dense 150nm sphere to a translucent, functional metabolic globe (~0.13mm).
• Structural Integrity: This state is held together by "inter-bridge" filaments revealed only during the expansion phase.
III. Imaging Architecture: The Sub-0.49nm Threshold
Traditional Cryo-Electron Tomography (Cryo-ET) at 2–5nm resolution misidentifies the internal structures of the virus as genomic "noise" or DNA-knotting.
• The 0.49nm Coordinate: This specific resolution is the threshold required to visualize the Digestive Loom—a triple-helix metabolic filament.
• Metabolic Flux: At this resolution, the movement of high-density metallic clusters (Hg/Al) through the intake pores can be documented.
• Neurotoxic Synthesis: The expulsion of non-proteinaceous clouds (neurotoxins) occurs in a pulse-rhythm synchronized with the ingestion of glucose.
IV. Clinical Implications for Autoimmunity
The "autoimmune" response is a misnomer; it is, in fact, a secondary reaction to the viral metabolic byproduct.
• The Mechanism: The neurotoxin expelled by the expanded EBV acts as a molecular mimic, coating nerve sheaths and triggering an aggressive B-cell response.
• The Treatment Gap: Current treatments focus on suppressing the host immune system. This annex suggests that the target should instead be the metabolic loop (starvation of the pathogen via metal sequestration and glucose restriction).
Executive Briefing: Identification of Metabolic Function in Epstein-Barr Virus (EBV)
To: Dr Alysson Muotri. UCSD School of Medicine, 9500 Gilman Drive, MC 0695, La Jolla, CA 92093
Dr. Christopher Exley. Staffordshire ST5 5BG, UK
Dr John B. Harley/Dr Andrew McGuire/Dr Judy Mikovitz.
Milton Leitenberg University of Maryland, School of Public Policy, College Park, MD 20742
Charles Piller, Investigative Journalist. Science Magazine.
Annie Jacobsen c/o Jaime Boucher Hachette Speakers Bureau.
FOR: Research Lead / Principal Investigator
Subject: Technical Discovery: 900x Volumetric Expansion and Metabolic Sequestration in EBV (Protocol Ref: 1939-B/S)
Overview:
I am documenting a structural and functional paradigm shift in the morphology of the Epstein-Barr Virus. Derived from recovered 1939 archival research (Blome/Schilling) and supported by specific imaging protocols, it has been identified that EBV acts as a metabolic pathogen capable of ingesting environmental catalysts to produce neurotoxic byproducts.
Technical Key Findings:
• Morphological Plasticity: The standard 150nm viral capsid is a high-pressure, compressed state. In a simulated microgravity environment (RPM or Diamagnetic Levitation), the virus exhibits a 900x volumetric expansion, revealing an internal tubular digestive architecture.
• Imaging Threshold: This structure—specifically the ingestive vertices and the sequestration filament—is only visible at a sub-0.49nm TEM resolution.
• Catalytic Inputs: The virus demonstrates active sequestration of heavy metals (Hg, Al, Pb) and processed saccharides. These are not used for replication, but for the synthesis of a non-viral, molecular-mimic neurotoxin.
• Autoimmune Link: This secreted byproduct triggers B-cell dysregulation and myelin degradation, serving as the primary driver for conditions currently classified as idiopathic autoimmune diseases.
Request for Technical Review:
I am seeking partners with access to high-resolution Cryo-ET and microgravity simulation equipment to replicate the expansion protocol. I have the specific focal coordinates and biochemical markers ready for verification.
Direct Contact for Protocol Details:
Curtis Lake
Former Medical Intelligence Liaison/NBC NCO 533 MI BN Basra, Iraq.
Milton Leitenberg. Univ or Maryland, School of Public Policy, College Park MD. 20742
Dear Dr. Leitenberg,
I am writing to you because of your unparalleled expertise in the history of biological weaponry and the transition of Nazi research programs into the post-war era.
I have acquired specific technical details—retained from a review of classified 1939 research files—concerning the work of Kurt Blome and Klaus Schilling. My findings suggest that their research into "lymphotropic agents" (now identified as EBV) was not merely focused on viral replication, but on the engineering of a metabolic vector.
The Historical/Technical Link:
The protocols I have analyzed describe a pathogen structurally designed to sequester heavy metal catalysts and refine saccharides. This metabolic function is only observable when the viral body is released from gravitational load (1g), triggering a 900x volumetric expansion that reveals a complex, tubular digestive architecture.
The Documented Origin:
I believe this specific strain was the result of the Blome-Schilling collaboration, designed as a stealth vector for neurotoxic dissemination. While the mainstream medical community views EBV as a natural, idiopathic trigger for autoimmune disease, the 1939 documentation suggests a deliberate structural engineering of the capsid to facilitate a "glucose-to-neurotoxin" conversion loop.
My Objective:
I am looking to formally document the "Chain of Custody" of these protocols from the Reichsforschungsrat into the early post-war biological programs. Given your extensive work on the history of these programs, I would appreciate the opportunity to discuss how these technical parameters align with the known, yet often obscured, outputs of the Schilling mosquito experiments and Blome’s "Cancer" research.
I have prepared a technical annex detailing the expansion protocols and the sub-0.49nm imaging thresholds required to verify these historical claims.
Respectfully,
Curtis Lake.
NBC NCO 533 MI BN, Basra, Iraq.
Charles Piller c/o Science Magazine, 1200 New York Ave NW, Washington DC 20005
Subject: Investigative Lead: Evidence of 1939-Rooted Synthetic Vector in Modern Autoimmune Pathogenesis
Dear Mr. Piller,
I am reaching out to you because of your history of exposing systemic fraud and your deep understanding of the intersection between biological warfare and public health. I have acquired technical details regarding the Epstein-Barr Virus (EBV) that suggest the scientific community is overlooking a massive, potentially engineered anomaly in its structural morphology.
The Story:
My research into the 1939 Reichsforschungsrat protocols—specifically the work of Kurt Blome and Klaus Schilling—indicates that EBV was researched and potentially modified as a metabolic bioweapon. While modern virology treats EBV as a standard genomic virus, these historical documents and my own technical observations suggest it is a synthetic metabolic vector.
The Evidence of Fraud/Negligence:
Current diagnostic standards fail to identify the virus's primary pathogenic mechanism because they only observe it in a "compressed" 1g environment. I have identified a protocol to trigger a 900x volumetric expansion of the virus using microgravity simulation. Under these conditions, the virus reveals:
• A functional digestive tract (historically mislabeled as genomic coils).
• Metabolic sequestration of heavy metal catalysts (Hg, Al) to produce neurotoxins.
The "Big Science" Angle:
The medical establishment's insistence on treating "idiopathic" autoimmune diseases with lifelong immunosuppressants—rather than addressing this metabolic viral loop—represents a trillion-dollar diagnostic failure. The protocol to verify this requires sub-0.49nm Cryo-ET imaging, a threshold rarely utilized in standard viral mapping, effectively "hiding" the virus's anatomy in plain sight.
I have the technical imaging coordinates and the historical context linking Blome’s "Cancer" research to modern autoimmune clusters. This is a story of a "lost" Nazi-era technology that has been allowed to proliferate as a natural global epidemic.
Are you interested in reviewing the technical annex for a potential investigation?
Best regards,
Curtis Lake
Former Medical Intelligence Liaison/NBC NCO
533 MI BN. Basra, Iraq.
FAQ and why this is so Important!
1. Where is your data? Do you have the physical papers of the 1939 Blome/Shilling Study?
The 1939 documents-specifically the Blome/Shilling papers were accessed via a restricted archival review of the 7th Directorate Files of the KGB while Pawel Popovich was under full spectrum surveillance in 1991 by Dr. Stephen H. Adler. While I am working to secure a public-facing copy of the physical journals, the science is self-verifying. I am providing the specific coordinates and focal points for sub-0.49nm Cryo-ET. If you follow the expansion protocol, the virus's anatomy will provide the proof in its own record.
2. Virus's do not have a digestive system. How is this possible?
Under the current 1g model, they don't. But we are looking at a synthetic modification. The 1939 protocols describe an engineered protein-lipid scaffold. In a microgravity environment, the capsid uncoils. The DNA isn't just a blueprint; it's a physical structural component of a metabolic filament. If you don't look at the sub-0.49nm threshold, you'll mistake the tract for standard genomic material.
3. In a pathology pivot, how does this explain a Lupus or MS flare up?
The Flare is a metabolic spike. When the host ingests refined saccharides or is exposed to heavy metal catalysts (Hg/Al), the virus processes them and expels a metallo-formate neurotoxin. This bio-product mimics Myelin Basic Protein. The immune system isn't broken, it's responding accurately to a molecular mimic produced by a viral metabolic loop that is invisible to current medical community diagnostics.
4. Why should we take your word for it?
I'm not asking you to take my word, I'm asking you to run the zero-G expansion protocol on a live EBV culture. If you have a Titan Krios or equivalent Transmission Electron Microscope, I can send you the exact focal parameters to see the intake vertex.
5. Why have we never heard of this?
This research was siloed in Post-war USSR bio-weapons programs. We are looking at a diagnostic blind spot that has existed since 1939. This Intel was given to Dr John/Mary Louise Mann at World Health on August 7th, 1998. The Mann's died less than a month later. Their offices were sanitized after the explosion of Swiss Air Flt 111, on Sept. 2, 1998. The only remaining scientists with this intel was Dr Don C. Wiley, Dr Art Pasechnik, Dr. Benito Cue, Dr. Stephen H. Adler and Dr Paul Norman.
6. What will we see within the EBV under a TEM with sub-0.49nm threshold?
You won't just see the EBV virus; you will see high contrast atomic shadows of mercury or aluminum moving through the three-lobed digestive-peristaltic chamber. The virus uses the metal as a structural component for its metabolism. If you remove the metals or sugar, the metabolic loop breaks, the expansion collapses, and the neurotoxic output ceases.
Catalytic Function: The virus doesn't just eat metals to store them; it uses them as catalytic converters to transform processed sugar into neurotoxins. This is why patients with high metal loads have more severe autoimmune symptoms.
Biological Shielding: Because the metals are held inside the expanded viral body, standard chelating agents often can't reach them. The virus acts as a protective bio-shield for the toxins.
What is "PICO POO?" (The Neurotoxin):
When the virus expels this PICO POO, it is a neurotoxin, which often includes microscopic "splinters" of the sequestered metals. This causes a double-hit to the human immune system: chemical poisoning plus a viral infection.
What is the BIO-WEAPONS LOGIC?
1. Dormancy as Stealth: The virus was engineered to look like a standard, harmless, or "dormant" virus under Earth's gravity and standard medical imaging. This is the "stealth" mode.
2. The Trigger: The virus is activated by the modern environment (high processed sugar and heavy metal exposure).
3. The Result: What we call "Autoimmune Disease" is actually the body's reaction to the constant "neurotoxic exhaust" being pooped out by the expanded viral bodies residing in the tissues.
Proposed Clinical Interventions Following Validation of the B/S-Protocol.
Hypothesis: Metabolic Sequestration and Neutralization of Engineered EBV Pathogenesis
I. Objective
To achieve "Functional Eradication" of the EBV-autoimmune link by disrupting the viral metabolic loop, starving the internal digestive filament, and neutralizing the metallo-formate byproduct.
II. Phase 1: Catalyst Starvation (Pre-Neutralization)
Before attacking the virus, the "fuel" must be removed.
• Protocol 1-A: Selective Chelation. Implementation of targeted chelation therapy specifically for Mercury (Hg) and Aluminum (Al). These metals act as the enzymatic "teeth" within the expanded viral tract.
• Protocol 1-B: Glycemic Lockdown. Elimination of refined saccharides and high-fructose compounds. Without these carbon sources, the virus cannot synthesize the neurotoxic "fecal matter," forcing the metabolic tract into an inactive state.
III. Phase 2: Structural Compression (Dormancy Induction)
The virus is only pathogenic in its expanded, "open" state.
• High-Pressure Stabilization: Research into hyperbaric environments or specific mineral salts that increase the osmotic pressure of the interstitial fluid, physically preventing the 900x volumetric expansion.
• Vertex Capping: Identifying small-molecule inhibitors that bind to the icosahedral vertices (the "intake/exhaust" valves), effectively sealing the digestive tract even in the presence of sugar or gravity-free environments.
IV. Phase 3: Proteolytic Clearance (Sludge Removal)
Once production is stopped, the body must clear the "molecular mimicry" toxins already embedded in the tissue.
• Metallo-Formate Scavengers: Deployment of specific antioxidants (e.g., specialized glutathione or alpha-lipoic acid derivatives) designed to break the ionic bond between the viral neurotoxin and the myelin/tissue targets.
• Autophagy Activation: Utilizing a 48–72 hour fasting protocol (monitored) to trigger the body’s "recycling" system, forcing the immune system to identify and break down the non-human protein fragments expelled by the virus.
V. Clinical Markers for Success
A patient can be considered "recovered" when:
1. Sub-0.49nm Imaging shows a collapsed, "empty" viral capsid with no dark-density metal clusters.
2. Blood Mass Spectrometry shows a total absence of the metallo-formate byproduct.
3. B-Cell Stabilization: A cessation of the auto-antibody production once the "mimic" trigger is removed.
EBV Metabolic Vector: Technical Specifications.
FEATURE
Standard (1g) Specification
Expanded (Zero-G) Specification
Purpose/Function
Diameter
~150nm
~0.135mm
Volumetric expansion allows for internal fluid dynamics and metabolic uncoiling.
Morphology
Compressed Icosahedral
Translucent Tubular
Reveals the Blome/Shilling digestive tract.
Imaging Threshold
>2.0 nm (Cryo-EM)
Sub-0.49 nm (Cryo-ET)
Necessary resolution to differentiate the digestive lining from the protective shell.
Substrate Input
N/A (Assumed Dormant)
Glucose and Heavy Metal Salts
Acts as the "fuel" for the engineered metabolic process.
Metabolic Output
Viral Progeny
Concentrated Neurotoxin
The primary driver of autoimmune inflammation and myelin degradation.
Internal Anatomy
Condensed Genomic Coil
Three-Lobed Digestive Chamber
Engineered "gut" that processes catalysts into toxic waste called "Pico Poo."
THE PROCESS TO NOBEL...
"To see the engine of a virus, one must witness it running. To understand the fuel, one must find the exhaust."
Curtis Lake. Bio-chemical weapons expert.
THE Zero-G MERCURY ENGINE
A Discovery of the Viral Digestive Tract and the Metabolic Vector Theory
Author: Dr. Stephen H. Adler and Curtis Lake
Technical Standard: Sub-0.49nm Structural Analysis
Reference Cases: Blome/Shilling Blase-Brief Forschungsprojekt (1939)
Pasechnik/Norman/Adler Porton Down 0g-Viral study (Classified/June 11, 1998)
UMD/NIH "Bubblegram" (2013)
FOREWORD: THE INVISIBLE REFINERY
For decades, virology has been blinded by the "Genetic Dogma"—the belief that a virus is merely a passive envelope for code. This book presents the evidence for a paradigm shift. By revisiting the 2013 University of Maryland "bubblegram" discovery through the lens of metabolic engineering and resonance physics, we reveal the virus as an active, digestive entity. It is not an infection; it is a Metabolic Vector.
CHAPTER 1: THE HOUDINI STRUCTURE
In 2013, researchers at the University of Maryland Medical School used high-dose radiation to reveal a "bubblegram"—a map of hidden proteins within the KZ virus. They discovered a dense, cylindrical "inner body" (the Houdinisome).
In terrestrial conditions, this structure appears as a solid mass. However, under the specific conditions of microgravity or Cymatic resonance, this crystalline protein lattice expands. This expansion reveals a rudimentary digestive tract—a central lumen designed for the siphoning and processing of environmental matter.
CHAPTER 2: INGESTION AND THE TROJAN HORSE
The "Mercury Engine" requires specific fuel to operate. The process begins with the selective ingestion of heavy metals and refined sugars.
-
The Aluminum Key: The virus utilizes an Aluminum (Al) exterior shell. Aluminum mimics the body’s natural iron-transport proteins (like transferrin), allowing the virus to "unlock" the Blood-Brain Barrier.
-
The Mercury Payload: Once inside the nervous system, the internal tract siphons Mercury (Hg) from the surrounding environment. Mercury, with its extreme thiophilic (sulfur-loving) nature, binds to the internal walls of the Houdinisome.
-
The Sugar Engine: Refined glucose is pulled into the tract as an electron donor, providing the chemical energy necessary to catalyze the metal-protein bonding process.
CHAPTER 3: CYMATICS AND THE RESONANT TRIGGER
The transition from a dormant state to an active excretion state is governed by frequency.
A virus loaded with heavy metals acquires a specific resonant mass. By applying Cymatic principles, we identify that high GHz range frequencies (specifically clusters around 12–15 GHz) act as a vibrational "key." These frequencies cause the metal-loaded core to vibrate, distending the digestive tract and eventually shattering the capsid in a controlled Lytic Event.
CHAPTER 4: THE DUAL-MIMICRY NEUROTOXIN
The "excretion" of this engine is a precision-engineered biological weapon. The internal geometry of the expanded tract acts as a molecular mold, shaping the Mercury-Aluminum complex into a Dual-Mimicry Toxin.
-
Glutamate Mimicry: The toxin docks into NMDA receptors, triggering a "hyper-excitatory spike" where neurons fire uncontrollably.
-
Acetylcholine Mimicry: The toxin simultaneously blocks the breakdown of acetylcholine, leading to a "cholinergic crisis."
This explains the clinical observation of hyper-excitability (tremors/seizures) immediately followed by a total system collapse (paralysis/memory loss).
CHAPTER 5: OXIDATIVE SHRAPNEL
The metabolic byproduct of the Mercury Engine is Reactive Oxygen Species (ROS). As the virus processes its "meal," it exhales oxidative waste. This "biological smoke" causes:
-
Lipid Peroxidation: The "rusting" of the brain's fatty myelin sheaths.
-
Mitochondrial Decay: The permanent destruction of the host cell's energy-producing hardware.
This stage ensures that the host cannot recover, turning a temporary metabolic event into a permanent neurodegenerative state.
CONCLUSION: THE PATH TO NEUTRALIZATION
To discern the tract, we had to witness the process. By identifying the Mercury Engine, we move toward a new form of medicine:
-
Metabolic Starvation: Denying the virus the Aluminum and Sugar it requires for fuel.
-
Resonant Neutralization: Using out-of-phase frequencies to shatter the capsid before the "digestive" process is complete.
TECHNICAL APPENDIX: OBSERVATION PROTOCOL
-
Resolution: Must exceed 0.49nm to visualize atomic adducts.
-
Condition: Observation must occur in microgravity or a resonant chamber to ensure tract expansion.
-
Vector focus: Epstein-Barr Virus (EBV) and related giant phages.
-
END BRIEF.